Saltar al contenido
Merck
  • Role of transient receptor potential vanilloid 1 in regulating erythropoietin-induced activation of endothelial nitric oxide synthase.

Role of transient receptor potential vanilloid 1 in regulating erythropoietin-induced activation of endothelial nitric oxide synthase.

Acta physiologica (Oxford, England) (2016-05-28)
Y-B Yu, K-H Su, Y R Kou, B-C Guo, K-I Lee, J Wei, T-S Lee
RESUMEN

Erythropoietin (EPO), the key hormone involved in erythropoiesis, beneficially affects endothelial cells (ECs), but the detailed mechanisms are yet to be completely understood. In this study, we investigated the role of transient receptor potential vanilloid type 1 (TRPV1), a ligand-gated non-selective calcium (Ca In ECs, EPO time dependently increased intracellular levels of calcium; this increase was abrogated by the Ca These findings indicate the EPO-induced Ca

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Capsazepine, ≥98% (HPLC), solid
Sigma-Aldrich
MISSION® esiRNA, targeting human ARHGAP4